New inhaled therapies for viral infections

One of our customers, Activoris Medizintechnik GmbH, today announced the strategic collaboration with CytoTools AG (ISIN DE000A0KFRJ1) for the development of respiratory treatments against diseases like COVID-19 and Influenza. ACliRA Consulting GmbH will be supporting this development with its expertise in scientific and regulatory strategy advice. See more details here...